Genetic testing of embryos for women aged 37-41
Part of Women’s health & pregnancy clinical trials.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 37 and 41 years old.
- You have a male partner, a female partner, or are using sperm from a donor.
- Your AMH level (ovarian reserve test) is at least 6.28 pmol/L, measured within the past year.
- This will be your first to fifth IVF/ICSI cycle (cycles before a successful birth don't count).
- You do not need special genetic testing for chromosome rearrangements or single-gene disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at embryo health using a DNA test called PGT-A for couples having IVF. It may help researchers better understand what the test can and cannot tell about which embryos are healthiest.
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
This study compares two ways of preparing sperm for IVF (a microfluidic chip versus a centrifuge method). It aims to see which method leads to more genetically normal embryos (euploid) when doing PGT (pre-implantation genetic testing).
This trial tests how well a hormone treatment (hMG) works for people doing IVF with genetic screening of embryos. It may help if you have normal ovarian reserve and are not using donor sperm.
This study looks at whether a hormone level measured inside the fluid around eggs (follicular fluid) can predict whether embryos have the correct number of chromosomes. It may help clinics choose which embryos are more likely to be healthy.
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.